Wyss Zürich Logo with claim Wyss Zürich Logo with claim
All News

Phire Therapeutics wins Venture Kick's second stage support

17-09-2021 – The Wyss Zurich project Phire and its startup win the Venture Kick's second stage of financial and entrepreneurial support. This support will help the project advance its development of an antibody-enabled blood stem cell transplantation treatment against Acute Myeloid Leukemia.

Wysszurich keyvisual phire

The team behind Phire Therapeutics found itself during a 4-year long collaborative effort between ETH Zurich and University Hospital Zurich. They are developing a novel immunologic approach to selectively eliminate the patient’s healthy and diseased hematopoietic cells and therefore enable HSCT and potential cure. The funds from Venture Kick will be used for Business Development and IP-related experiments.

Similar News

MUVON at the IFAS Innovation Challenge 2021 ©Cosanum 27-09-2021

MUVON wins second place at IFAS Innovation Challenge 2021

MUVON Therapeutics was selected as one of twelve finalists for 2021's IFAS Innovation Challenge and places second in the final pitching round.
Wysszurich keyvisual seervision 19-10-2021

Seervision raises 3.7M CHF to accelerate market expansion

Seervision has successfully completed a financing round to build upon its sales channel partnerships and help companies professionalize their hybrid event presence in a wide range of use cases.
Wysszurich keyvisual hylomorph 03-12-2021

HYLOMORPH successfully raises 5.2M CHF during Series-B round

The Wyss Zurich alumni project HYLOMORPH, a rapidly growing clinical-stage medtech startup with a history of national and international recognition, completed a CHF 5.2 million Series-B financing...